# Viridian Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/viridian-therapeutics-inc-de |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 15 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-24T04:45:51.213875+00:00 |
| Last reviewed | 2026-10-24T04:45:51.213875+00:00 |

## Identity

- Legal name: Viridian Therapeutics, Inc.\DE
- Display name: Viridian Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-24T04:45:51.213875+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.849 |
| Directors | 7 |
| Committees | 0 |
| Governance events | 11 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Arlene M. Morris: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:5
- Chris Cain: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:6
- Jeff Ajer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:7
- Jennifer K. Moses: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:8
- Sarah Gheuens: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:9
- Stephen Mahoney: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:10
- Tomas Kiselak: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:11

## Executive leadership

- Jennifer Tousignant: Named Executive Officer / Proxy. Status: current. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:12
- Sean O. Mahoney: Named Executive Officer / Proxy. Status: current. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:13
- Seth Harmon: Named Executive Officer / Proxy. Status: current. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:14
- Thomas Beetham: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:15

## Governance events

- DIRECTOR_APPOINTED: Stephen Mahoney seat on Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:17w7mmwjdbtk2
- DIRECTOR_APPOINTED: Tomas Kiselak seat on Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:1yvtap71ddybw7
- EXECUTIVE_APPOINTED: Jennifer Tousignant executive of Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:ktq0h31ola71x
- EXECUTIVE_APPOINTED: Sean O. Mahoney executive of Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:1f84cor13m4bv7
- EXECUTIVE_APPOINTED: Seth Harmon executive of Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:govy5o152ryua
- EXECUTIVE_APPOINTED: Thomas Beetham executive of Viridian Therapeutics, Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:8xadqn1gn7kvz
- DIRECTOR_APPOINTED: Chris Cain seat on Viridian Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:14ehfrq1hbt7rw
- DIRECTOR_APPOINTED: Jeff Ajer seat on Viridian Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:17ebuvd33yhq1
- DIRECTOR_APPOINTED: Sarah Gheuens seat on Viridian Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:11iqgh9jtbe01
- DIRECTOR_APPOINTED: Jennifer K. Moses seat on Viridian Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:1b7idt439g78e
- DIRECTOR_APPOINTED: Arlene M. Morris seat on Viridian Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-24T04:45:51.213875+00:00. event_id=alpha:event:transition:iiq7lzu8skux

## Scoped resources

- `alpha://company/viridian-therapeutics-inc-de` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record
- `alpha://company/viridian-therapeutics-inc-de/identity` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=identity
- `alpha://company/viridian-therapeutics-inc-de/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=corporate-structure
- `alpha://company/viridian-therapeutics-inc-de/board` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=board
- `alpha://company/viridian-therapeutics-inc-de/committees` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=committees
- `alpha://company/viridian-therapeutics-inc-de/leadership` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=leadership
- `alpha://company/viridian-therapeutics-inc-de/ownership` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=ownership
- `alpha://company/viridian-therapeutics-inc-de/financials` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=financials
- `alpha://company/viridian-therapeutics-inc-de/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=capital-structure
- `alpha://company/viridian-therapeutics-inc-de/compensation` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=compensation
- `alpha://company/viridian-therapeutics-inc-de/governance` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=governance
- `alpha://company/viridian-therapeutics-inc-de/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=shareholder-governance
- `alpha://company/viridian-therapeutics-inc-de/audit` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=audit
- `alpha://company/viridian-therapeutics-inc-de/legal` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=legal
- `alpha://company/viridian-therapeutics-inc-de/risk` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=risk
- `alpha://company/viridian-therapeutics-inc-de/cyber` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=cyber
- `alpha://company/viridian-therapeutics-inc-de/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=ai-governance
- `alpha://company/viridian-therapeutics-inc-de/agents` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=agents
- `alpha://company/viridian-therapeutics-inc-de/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=ecosystem
- `alpha://company/viridian-therapeutics-inc-de/events` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=events
- `alpha://company/viridian-therapeutics-inc-de/relationships` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=relationships
- `alpha://company/viridian-therapeutics-inc-de/assessments` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=assessments
- `alpha://company/viridian-therapeutics-inc-de/evidence` (contract): https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Arlene M. Morris: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:5. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Chris Cain: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Jeff Ajer: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Jennifer K. Moses: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Sarah Gheuens: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Stephen Mahoney: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:10. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Tomas Kiselak: Director. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:11. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a.
- Jennifer Tousignant: Named Executive Officer / Proxy. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:12. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:155f2f8802d12ca589830c0421d4e3b95395e7f6ffa8576ca4db79cf7528ead2.
- Sean O. Mahoney: Named Executive Officer / Proxy. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:13. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b1750d4d2f9075af3dedbede7db42d507d4a7be6bcacac3ba0e29bc9fa3d078.
- Seth Harmon: Named Executive Officer / Proxy. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:14. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cc15c6ca786a2afed24b7874fe61f123c7d566c6ab8c8060892cb5ea4a0896da.
- Thomas Beetham: Named Executive Officer. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:leadership_role:15. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ec03e0a01a468d0dece9580f787bfec41e90f458dc850d2e2a4a89f2bf108868.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Viridian Therapeutics, Inc.\DE. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6d1786ccfc007dc90aa6159559ed5c1c8db72a1682d199977e8183eb4ead1be3.

## Entity Status

- Public listing published. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6d1786ccfc007dc90aa6159559ed5c1c8db72a1682d199977e8183eb4ead1be3.

## Published Fact

- US. Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6d1786ccfc007dc90aa6159559ed5c1c8db72a1682d199977e8183eb4ead1be3.

## Security Listing

- VRDN (NASDAQ). Claim: alpha:claim:company:a5490a4b-60ac-47ba-af9f-43abbdf20d86:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6d1786ccfc007dc90aa6159559ed5c1c8db72a1682d199977e8183eb4ead1be3.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:6d1786ccfc007dc90aa6159559ed5c1c8db72a1682d199977e8183eb4ead1be3: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/viridian-therapeutics-inc-de).
- alpha:projection-evidence:document:1dbff00e52d8ed9a0a9e3cb6f8e08fa5dccabd8b4165288ddff2f1b97b95642a: [DEF 14A d904278ddef14a.htm](https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm).
- alpha:projection-evidence:document:155f2f8802d12ca589830c0421d4e3b95395e7f6ffa8576ca4db79cf7528ead2: [VRDN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm).
- alpha:projection-evidence:document:6b1750d4d2f9075af3dedbede7db42d507d4a7be6bcacac3ba0e29bc9fa3d078: [VRDN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm).
- alpha:projection-evidence:document:cc15c6ca786a2afed24b7874fe61f123c7d566c6ab8c8060892cb5ea4a0896da: [VRDN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm).
- alpha:projection-evidence:document:ec03e0a01a468d0dece9580f787bfec41e90f458dc850d2e2a4a89f2bf108868: [VRDN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1590750/000119312526160344/d904278ddef14a.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/viridian-therapeutics-inc-de)
- [Public Markdown](https://registry.alpha.ac/companies/viridian-therapeutics-inc-de.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/viridian-therapeutics-inc-de?format=jsonld)
- MCP resource: `alpha://companies/viridian-therapeutics-inc-de` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-24T14:22:26.009707+00:00; recorded 2026-10-24T14:22:26.009707+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.